课题基金 / 基金详情

Molecular and immunological study on the pathogenesis of hepatitis C

Molecular and immunological study on the pathogenesis of hepatitis C
丙型肝炎发病机制的分子和免疫学研究
批准号:
07407015
负责人:
IMAWARI Michio
金额:
$8.13万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1998

项目摘要

项目成果

IMAWARI Michio的其他基金

相似基金

相关文献

中文摘要
翻译
在本研究中,我们证明了HLAB 44阳性的丙型肝炎患者对HCV核心抗原a.a. 88-96患者血清HCVRNA水平较低,提示CTL可抑制HCV的生长。因此,HCV感染的CTL应答不足以清除病毒。a. 88-96型仅在27例HLA B44阳性患者中观察到3例。3种变异体均能被CTL有效识别,但其中2种变异体不能有效诱导CTL,另1种变异体能诱导CTL,而且当少量变异体HCV与野生型HCV共存时,特异性CTL识别特异性变异表位的诱导作用被抑制,HCV特异性CTL通过前体-、Fas配体-和Fas配体-识别并杀伤HCV感染的靶细胞。基于TNF的机制。此外,激活的CTL通过Fas配体和基于TNF的机制杀死旁观者敏感的未感染细胞。这些机制可能有助于肝脏炎症的扩大。
英文摘要
In the present study, we demonstrated that HLA B44-positive hepatitis C patients with demonstarable CTL response to HCV core antigen a.a. 88-96 had lower levels of serum HCV RNA, suggesting that CTL may suppress the outgrowth of HCV.In addition, CTh response was observed to multiple HCV epitopes in the same patients. Thus CTL response to HCV infection is not strong enough to eliminate the virus.The variation of amino acid in HCV core a. a. 88-96 was observed only 3 of 27 HLA B44-positive patients. All three variants could be recognized by CTL as effectively as wild-type HCV antigen, but two of three variants could not induce CTL effectively while the other one could induce CTL.Furthermore, when a small amount of variant HCV co-existed with wild-type HCV, the induction of CTL recognizing spesifically variant epitope was sppressed.HCV-specific CTL recognized and killed HCV-infected target cells by perform-, Fas ligand-, and. TNF-based mechanisms. In addition, activated CTL killed bystander sensitive non-infected cells by Fas ligand and TNF-based mechanisms. The mechanisms may contribute to the expansion of inflammation in the liver.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
Ando,Kazuki: "Perforin,Fas/Fas Ligand,TNF-α pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL" Journal of Immunology. 158. 5283-5291 (1997)
Ando,Kazuki:“穿孔素、Fas/Fas 配体、TNF-α 途径作为丙型肝炎病毒特异性人类 CTL 的特异性和旁观者杀伤机制”《免疫学杂志》158. 5283-5291 (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ando, Kazuki: "Perforin, Fas/Fas ligand, TNF-α pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL" Journal of Immunology. 5283-5291 (1997)
Ando, Kazuki:“穿孔素、Fas/Fas 配体、TNF-α 途径作为丙型肝炎病毒特异性人类 CTL 的特异性和旁观者杀伤机制”《免疫学杂志》5283-5291 (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kita, Hiroto: "A minimal and optimul cytotoxic T cell epitope within hepatitis C virus nucleoprotein" Jpurnal of General Virology. 76. 3189-3193 (1995)
Kita, Hiroto:“丙型肝炎病毒核蛋白内的最小且最佳的细胞毒性 T 细胞表位”《普通病毒学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kaneko, Takashi.: "Impaired induction of cytotoxic T lymphocytes by antagonis of a weal agonist borne by a variant hepatitis C virus epitope" European Journal of Immunology. 27. 1782-1787 (1997)
Kaneko, Takashi.:“丙型肝炎病毒变异表位所携带的 Weal 激动剂的拮抗作用对细胞毒性 T 淋巴细胞的诱导作用受损”《欧洲免疫学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 20 条
    Research on cytotoxic T cell responses to hepatitis C virus infection
    Analysis of cellular immune responses in perihperal blood and liver tissues in HCV infection
    • 批准号:
      11470136
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $3.01万
    • 财政年份:
      1999
    • 负责人:
      IMAWARI Michio
    • 依托单位:
    Development of T-cell vaccine for hepatitis C virus
    • 批准号:
      07557047
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $6.14万
    • 财政年份:
      1995
    • 负责人:
      IMAWARI Michio
    • 依托单位:
    Studies on the Immunopathogenesis of Viral Hepatitis C
    海外基金